Advocate Magazine
Subscribe To
The Advocate

Health

Discover the Health section of The Advocate, where readers can find the latest news on medicine, fitness, mental and physical wellbeing, scientific developments, and diseases that affect the LGBT community. Read the most recent on gay health, AIDS and HIV news, pregnancy and sex from experts like doctors and researchers. Learn about news related to health insurance, statistics, changing laws and government policy, and tools that can be used in preventing and curing illnesses in the United States and beyond.

More than 2,000
people participated in the annual AIDS walk to benefit
Nashville CARES on October 8 in Nashville, walk organizers
told The Tennessean. Nashville CARES officials say
proceeds from the walk are expected to reach the
fund-raiser’s $140,000 goal. Country singer
Kathy Mattea and Miss Tennessee 2005 Tara Burns
participated in the fund-raiser. All money raised will

October 18 2005 12:00 AM

Researchers at
the Jonsson Comprehensive Cancer Center at the University
of California, Los Angeles have uncovered the mechanism by
which an antibody blocks the growth of prostate cancer
in animal models, a discovery that could pave the way
for development of a new molecularly targeted therapy.

October 18 2005 12:00 AM

A study conducted
by USA Today shows that 4% of all homeless
people in the United States are HIV-positive. The data was
drawn from information reported from 460 U.S. regions to the
Department of Housing and Urban Development. The study
found that about 730,000 Americans—or about one
of every 400 residents—are either temporarily or
chronically homeless. The data also showed that about 29% of

October 15 2005 12:00 AM

The National
Institutes of Health this week launched a Phase II
clinical trial of a vaccine aimed at preventing HIV
infection, The Wall Street Journal reports. The
vaccine, called HVTN 204, uses synthetic HIV genes to
prime the immune system to recognize and attack the
virus when it tries to enter the body. The vaccine
focuses on three separate strains of HIV—strains A,

October 15 2005 12:00 AM

Newly updated
treatment guidelines issued by the Department of Health and
Human Services support the use of the fusion inhibitor
Fuzeon with an active boosted protease inhibitor in
patients with three-class virologic failure, as this
treatment approach results in better and more prolonged
virologic suppression than other regimens. The evidence
cited in the treatment guidelines update includes

October 15 2005 12:00 AM

Even when HIV
viral levels are controlled through antiretroviral therapy,
the virus can still damage certain types of brain tissue,
researchers from the University of California, Los
Angeles, and the University of Pittsburgh report in
the Proceedings of the National Academy of
Sciences.
The scientists used 3-D magnetic
resonance imaging on the brains of 26 HIV-positive and 14

October 15 2005 12:00 AM

An advisory panel
for the Food and Drug Administration is scheduled to
meet on November 3 to consider making the OraQuick rapid HIV
antibody test available for over-the-counter purchase
and home use, The New York Times reports. The test,
called the OraQuick Advance Rapid HIV 1/2 Antibody
Test, can produce results in about 20 minutes from
oral samples. The tests are currently available only

October 15 2005 12:00 AM
1